Cost-effectiveness of combination fluticasone propionate–salmeterol 250/50 μg versus salmeterol in severe COPD patients

Autor: A Dalal, Meaghan St Charles, Hans V Petersen, et al

Publikováno v: International Journal of COPD, Vol 2010, Iss default, Pp 179-187 (2010)

Anand A Dalal1, Meaghan St Charles2, Hans V Petersen2, Melissa H Roberts2, Christopher M Blanchette2, Kathy Manavi-Zieverink31US Health Outcomes, GlaxoSmithKline, Research Triangle Park, NC, 2Division of Clinical and Outcomes Research, Lovelace Respi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doajarticles::fd84a6748fc7e464312f58efe0c79dd7
http://www.dovepress.com/cost-effectiveness-of-combination-fluticasone-propionatendashsalmetero-a4571

Webinar Training: an acceptable, feasible and effective approach for multi-site medical record abstraction: the BOWII experience

Autor: Kerri M. Clough-Gorr, Virginia P. Quinn, Tessa J. Kerby, Chantal Avila, Ann M. Geiger, Meaghan St Charles

Publikováno v: Avila, Chantal C.; Quinn, Virginia P.; Geiger, Ann M.; Kerby, Tessa J.; St Charles, Meaghan; Clough-Gorr, Kerri M. (2011). Webinar Training: an acceptable, feasible and effective approach for multi-site medical record abstraction: the BOWII experience. BMC research notes, 4, p. 430. London: Biomed Central 10.1186/1756-0500-4-430
BMC Research Notes, Vol 4, Iss 1, p 430 (2011)
BMC Research Notes

Background Abstractor training is a key element in creating valid and reliable data collection procedures. The choice between in-person vs. remote or simultaneous vs. sequential abstractor training has considerable consequences for time and resource

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01351d351f4f6e81fbed1a213a7e5249
https://doi.org/10.1186/1756-0500-4-430

Cost-effectiveness of combination fluticasone propionate–salmeterol 250/50 μg versus salmeterol in severe COPD patients

Autor: Hans Petersen, Anand A. Dalal, Kathy Manavi-Zieverink, Christopher M. Blanchette, Meaghan St Charles, Melissa H. Roberts

Publikováno v: International Journal of Chronic Obstructive Pulmonary Disease

Anand A Dalal1, Meaghan St Charles2, Hans V Petersen2, Melissa H Roberts2, Christopher M Blanchette2, Kathy Manavi-Zieverink31US Health Outcomes, GlaxoSmithKline, Research Triangle Park, NC, 2Division of Clinical and Outcomes Research, Lovelace Respi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b261e720197e549e1f2c541847140758
https://www.dovepress.com/cost-effectiveness-of-combination-fluticasone-propionatendashsalmetero-peer-reviewed-article-COPD

A cost-effectiveness analysis of pioglitazone plus metformin compared with rosiglitazone plus metformin from a third-party payer perspective in the US

Autor: Robert W. Baran, Sandra L. Tunis, Michael E. Minshall, Meaghan St Charles, Bhavik J. Pandya

Publikováno v: Current medical research and opinion. 25(6)

The long-term cost-effectiveness of using pioglitazone plus metformin (Actoplusmet dagger) compared with rosiglitazone plus metformin (Avandamet double dagger) in treating type 2 diabetes (T2DM) was assessed from a US third-party payer perspective.Cl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5006793d9e1271290911dab768b2c32
https://pubmed.ncbi.nlm.nih.gov/19419339

Health economic comparison between continuous subcutaneous insulin infusion and multiple daily injections of insulin for the treatment of adult type 1 diabetes in Canada

Autor: Meaghan St Charles, Michael E. Minshall, Sandra L. Tunis, Hamid Sadri

Publikováno v: Clinical therapeutics. 31(3)

Background: Patients with type 1 diabetes mellitus (DM) may be treated with insulin via multiple daily injections (MDI) or continuous subcutaneous insulin infusion (CSII). Objective: The purpose of this study was to evaluate the projected long-term c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43cca92620e0d254a614a2c5a2ecd18b
https://pubmed.ncbi.nlm.nih.gov/19393856